Diagnostics

  • NHS to expand CDCs across England

    The UK government has announced £237m for 36 community diagnostic centres (CDCs) across England. CDCs are local sites, often on high streets, in shopping centres or retail parks, where patients can get tests such as MRI and CT scans without going to hospital. The investment will pay for four new centres in Gorton [...]

  • Newborn DNA screening: What’s changing in the UK and where private testing fits

    Article produced in association with London Pregnancy Clinic Within the first few days of life, every baby born in England is offered a blood spot test, commonly known as the heel prick test.   The NHS Newborn Blood Spot Screening Programme screens for nine rare but serious conditions and has been responsible for [...]

  • Women’s hereditary cancer testing: From specialist to self-refer

    Article produced in association with Jeen Health and Spital Clinic Genetic testing for hereditary cancer risk in women has, for much of its clinical history, been available only through a referral pathway involving a GP, a clinical genetics team and a family history review meeting specific risk thresholds. The arrival of direct-access private testing has [...]

  • Why the UK must rethink prostate cancer screening

    By Dr Karan Wadhwa, consultant urological surgeon at Phoenix Hospital Group and clinical director at CHAPS In the UK, around one in five men dies before the age of 65, many from conditions that are preventable or far more treatable when detected early. Prostate cancer is central to that challenge. It is the most common [...]

  • What is SmartNT? Inside the protocol improving first-trimester assessment for increased nuchal translucency

    Article produced in association with London Pregnancy Clinic First-trimester ultrasound is a routine part of antenatal care across the UK. For most expectant parents, the nuchal translucency scan offers the first detailed visual assessment of the pregnancy and returns a reassuring result. For a smaller subset, however, a measurement above the expected range introduces a [...]

  • Scotland to test newborns for rare genetic condition in UK first

    Scotland has become the first part of the UK to test newborn babies for SMA, a rare genetic condition that causes progressive muscle weakness. The condition was recently highlighted by singer Jesy Nelson, formerly of Little Mix, whose twin baby daughters have been diagnosed with SMA. Babies can be identified as having SMA [...]

  • Phoenix Hospital Group launches new Prostate MRI Cancer Screening Service

    Phoenix Hospital Group has announced the launch of its new Prostate MRI Cancer Screening Service, now available at its Harley Street Health District hospital in central London and at Phoenix Chelmsford Hospital in Essex. The service has been introduced to encourage men to take a proactive approach to their wellbeing.  The Group also offers prostate [...]

  • Blood test detects brain tumours with 90% accuracy

    Scientists have made a significant step towards a blood test that detects brain tumours and monitors them in real time. The new test is 90 per cent accurate and could be used by GPs to pick up glioblastomas. It is also being expanded to include other types of brain tumour. The study, led by scientists [...]

  • Women’s health screening in 2026: Why combining GP assessment, ultrasound and genetics delivers better outcomes

    Article produced in association with Spital Clinic and Jeen Health The Women's Health Strategy for England, published in 2022, identified significant gaps in how women's health needs are met across the life course. Among the issues highlighted were poor access to specialists, delays in diagnosis for conditions such as endometriosis and PCOS, and a healthcare [...]

  • Magentus launches UK advisory board to strengthen clinical diagnostics strategy

    Magentus, a leading name in clinical diagnostics, announces the formation of a UK Advisory Board to guide the next phase of its strategy and reaffirm its long-term commitment to the UK health system. The announcement marks a significant milestone in Magentus’ renewed leadership in the UK market. It reinforces the company’s focus on earlier diagnosis, [...]